From Financial Modeling Prep: 2024-10-25 10:37:00

DexCom (NASDAQ:DXCM) beat Q3 earnings estimates with adjusted EPS of $0.45, above the expected $0.43. Revenue reached $994.2 million, a 2% increase YoY, slightly exceeding estimates. However, the slower revenue growth caused a 2% drop in shares. U.S. revenue declined by 2%, while international sales grew by 12%.

Despite the revenue slowdown, DexCom reaffirmed its full-year 2024 revenue guidance of $4.00-$4.05 billion, showing 11-13% organic growth. This projection is slightly higher than the Street’s expectation of $4.01 billion.



Read more at Financial Modeling Prep:: DexCom Shares Drop 2% as Slowing Revenue Growth Ov…